The kallikreins: Old proteases with new clinical potentials

Thrombosis and Haemostasis

Volumn 110, Issue 3, 2013, Pages 396-398

  Schmitt, Manfred ^a   Renné, Thomas ^b,c   Scorilas, Andreas ^d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; COLLAGEN; FIBRONECTIN; G PROTEIN COUPLED RECEPTOR; KALLIKREIN; KALLIKREIN 2; KALLIKREIN 3; KALLIKREIN 5; KALLIKREIN B1 PROTEIN; MATRIX METALLOPROTEINASE; PROSTATE SPECIFIC ANTIGEN; PROTEINASE ACTIVATED RECEPTOR; SERINE PROTEINASE; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; UNCLASSIFIED DRUG; UROKINASE; UVOMORULIN; VITRONECTIN;

BLOOD PRESSURE REGULATION; BODY FLUID; CANCER GROWTH; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CELL SURVIVAL; DIABETES MELLITUS; DIGESTIVE SYSTEM CANCER; EDITORIAL; GENE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KLKB1 GENE; NEOPLASM; NONHUMAN; OVARY CANCER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SKIN DISEASE; TUMOR INVASION;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; MALE; MICE; NEOPLASMS; PEPTIDE HYDROLASES; PLASMA KALLIKREIN; RISK; THROMBOSIS; TISSUE KALLIKREINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84883245025     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-07-0583     Document Type: Editorial

References (21)

1. Schmitt M, Magdolen V. Using kallikrein-related peptidases (KLK) as novel cancer biomarkers. Thromb Haemost 2009; 101: 222-224.
2. Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 2004; 4: 876-890.
3. Clements JA. Reflections on the tissue kallikrein and kallikrein-related peptidase family-from mice to men-what have we learnt in the last two decades? Biol Chem 2008; 389: 1447-1454.
4. Kontos CK, Scorilas A. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers. Clin Chem Lab Med 2012; 50: 1877-1891.
5. Lundwall A. Old genes and new genes: The evolution of the kallikrein locus. Thromb Haemost 2013; 110: 469-475.
6. Vickers AJ, Roobol MJ, Lilja H. Screening for prostate cancer: early detection or overdetection? Annu Rev Med 2012; 63: 161-170.
7. Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem 2007; 53: 1423-1432.
8. Pathak M, Wong SS, Dreveny I, et al. Structure of plasma and tissue kallikreins. Thromb Haemost 2013; 110: 423-433.
9. Ekholm IE, Brattsand M, Egelrud T. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? J Invest Dermatol 2000; 114: 56-63.
10. Fischer J, Meyer-Hoffert U. Regulation of kallikrein-related peptidases in the skin-from physiology to diseases to therapeutic options. Thromb Haemost 2013; 110: 442-449.
11. Sotiropoulou G, Pampalakis G. Targeting the kallikrein-related peptidases for drug development. Trends Pharmacol Sci 2012; 33: 623-634.
12. Kontos CK, Mavridis K, Talieri M, et al. Kallikreinrelated peptidases (KLKs) in gastrointestinal cancer: Mechanistic and clinical aspects. Thromb Haemost 2013; 110: 450-457.
13. Dorn J, Bayani J, Yousef GM, et al. Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies. Thromb Haemost 2013; 110: 408-422.
14. Thorek DLJ, Evans MJ, Carlsson SV, et al. Prostate specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Thromb Haemost 2013; 110: 484-492.
15. Waeckel L, Potier L, Richer C, et al. Pathophysiology of genetic deficiency in tissue kallikrein activity in mouse and man. Thromb Haemost 2013; 110: 476-483.
16. Fink E, Bhoola KD, Snyman C, et al. Cellular expression of plasma prekallikrein in human tissues. Biol Chem 2007; 388: 957-963.
17. Marcondes S, Antunes E. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system. Curr Med Chem Cardiovasc Hematol Agents 2005; 3: 33-44.
18. Björkqvist J, Jämsä A, Renné T. Plasma kallikrein: the bradykinin-producing enzyme. Thromb Haemost 2013; 110: 399-407.
19. Feener EP, Zhou Q, Fickweiler W. Role of plasma kallikrein in diabetes and metabolism. Thromb Haemost 2013; 110: 434-441.
20. Pruneau D, Belichard P, Sahel JA, et al. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy. Curr Opin Investig Drugs 2010; 11: 507-514.
21. de Maat S, van Dooremalen S, de Groot PG, et al. A nanobody-based method for tracking factor XII activation in plasma. Thromb Haemost 2013; 110: 458-468.